Finance

Beta
Lists
DVLA:IDX
Darya-Varia Laboratoria Tbk PT
IDR 1,500.00
-1.64%
(-25.00) 1D
Jun 5, 3:46:55 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for DVLA...
Open
IDR 1,525
High
IDR 1,525
Low
IDR 1,500
Mkt. cap
1.68T
Avg. vol.
19.80K
Volume
29.40K
Dividend
7.20%
Quarterly dividend
IDR 27
Ex-dividend date
Oct 29, 2025
P/E ratio
11.97
52-wk high
IDR 1,740
52-wk low
IDR 1,500
EPS
IDR 125
Shares outstanding
1.12B
No. of employees
1K
Open
IDR 1,525
High
IDR 1,525
Low
IDR 1,500
Mkt. cap
1.68T
Avg. vol.
19.80K
Volume
29.40K
Dividend
7.20%
Quarterly dividend
IDR 27
Ex-dividend date
Oct 29, 2025
P/E ratio
11.97
52-wk high
IDR 1,740
52-wk low
IDR 1,500
EPS
IDR 125
Shares outstanding
1.12B
No. of employees
1K
News stories
From sources across the web
About Darya-Varia Laboratoria Tbk PT
CEO-
Employees1.35K
Founded1976
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
541.81B
542.09B
603.56B
594.80B
Cost of goods sold
257.37B
248.96B
282.05B
293.42B
Cost of revenue
257.37B
248.96B
282.05B
293.42B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
227.58B
240.88B
325.49B
232.36B
Operating expense
223.99B
240.85B
321.90B
229.76B
Total operating expenses
481.35B
489.81B
603.94B
523.18B
Operating income
60.45B
52.28B
-389.20M
71.62B
Other non operating income
-
-
-
-
EBT including unusual items
59.24B
55.36B
1.20B
72.98B
EBT excluding unusual items
58.43B
54.88B
742.83M
72.98B
Income tax expense
16.66B
12.47B
1.59B
17.67B
Effective tax rate
28.13%
22.52%
131.98%
24.21%
Other operating expenses
-3.59B
-26.40M
-3.59B
-2.60B
Net income
42.57B
42.89B
-384.24M
55.31B
Net profit margin
7.86%
7.91%
-0.06%
9.30%
Earnings per share
-
-
-
-
Interest and investment income
1.29B
1.08B
1.05B
662.79M
Interest expense
-9.00M
-7.88M
-5.36M
-1.93M
Net interest expenses
1.28B
1.07B
1.04B
660.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
76.37B
69.92B
18.80B
92.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more